Pharmaceutical
Large, multi-phase R&D portfolios with enterprise governance and globally shared functions.
Industries · Life Sciences
Delivery experience in enterprise biopharmaceutical environments — where R&D portfolios are complex, governance is rigorous and planning data drives major investment decisions.
Delivery experience within top global biopharmaceutical organizations.
The context
The platform is the same. The planning problem is not — and configuration has to reflect it.
Programs span years and development phases, and plans must adapt as assets progress, pause or stop.
Portfolio reviews and stage-gate decisions depend on consistent, well-defined and auditable data.
Specialist functions support many programs at once, making capacity and demand planning central to delivery.
Budgets, forecasts and actuals need to reconcile across programs, functions and finance systems.
Platform changes typically move through formal change control, documented testing and release governance.
Where we help
Portfolio structures, prioritization and scenario views that reflect how the pipeline is governed.
Templates, schedules and workflows that fit how development programs are run.
Demand and capacity models across functions, roles and programs.
Cost structures, forecasts and actuals that reconcile with finance.
PEX reports, dashboards and portfolio review packs leadership can rely on.
Reliable data flows with finance, HR, clinical operations and data platforms.
Segments
Large, multi-phase R&D portfolios with enterprise governance and globally shared functions.
Growing pipelines where planning maturity has to scale quickly with the organization.
Product development portfolios balancing engineering, regulatory and commercial milestones.
The same platform depth applies to other complex enterprise environments, with delivery experience in large retail, aerospace & defense, and oil & gas organizations.
Whether it's an implementation, a reporting overhaul, an upgrade or additional delivery capacity, we'd welcome the conversation.